COVID-19

As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives. Are our rheumatic patients at…

COVID-19 brought many changes to our clinical practice, but the shift from face-to-face consultations to telemedicine has been immense for clinicians and patients alike. A simple Twitter poll which I…

Friday was the first full day of scientific sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day one: Safety of Recombinant Zoster Vaccine (RZV) (Abstract 0452…

I recently had the pleasure of interviewing my friend and colleague, Dr. Cassie Calabrese, rheumatology and infectious disease expert at the Cleveland Clinic, regarding the 6 things you need to know…

Since the beginning of the pandemic, rheumatologists scrambled to figure out how the SARS-CoV-2 virus will affect their patients with immune mediated inflammatory diseases (IMID).  Will…

Infection in the setting of autoimmune rheumatic disease (ARD) has been the subject of increasing research and clinical interest for decades. Even before the advent of disease-modifying anti-…